Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 38,432 | 42,177 | 40,340 | 38,800 | 33,620 |
| Cost of Goods | 1,613 | 1,174 | 925 | 797 | 709 |
| Gross Profit | 36,819 | 41,003 | 39,415 | 38,003 | 32,911 |
| Operating Expenses | 55,344 | 56,354 | 50,948 | 52,398 | 48,028 |
| Operating Income | -17,912 | -15,177 | -10,608 | -13,598 | -14,408 |
| Interest Expense | 1,155 | 2,972 | 660 | 658 | 132 |
| Other Income | 918 | 7,111 | -7,749 | -898 | 1,386 |
| Pre-tax Income | -18,149 | -11,038 | -19,017 | -15,154 | -13,154 |
| Income Tax | 229 | 6,580 | -1,223 | -1,925 | -2,064 |
| Net Income Continuous | -18,378 | -17,618 | -17,794 | -13,229 | -11,090 |
| Net Income | $-18,378 | $-17,618 | $-17,794 | $-13,229 | $-11,090 |
| EPS Basic Total Ops | -0.46 | -0.45 | -0.46 | -0.34 | -0.29 |
| EPS Basic Continuous Ops | -0.46 | -0.45 | -0.46 | -0.34 | -0.29 |
| EPS Diluted Total Ops | -0.46 | -0.42 | -0.46 | -0.34 | -0.32 |
| EPS Diluted Continuous Ops | -0.46 | -0.46 | -0.46 | -0.34 | -0.28 |
| EBITDA(a) | $-13,208 | $-10,147 | $-5,163 | $-8,846 | $-9,837 |